Kevin Wong

Director, Health Policy and Patient Access

Novartis Pharmaceuticals Inc.

I have led numerous teams in preeminent organizations within the pharmaceutical industry (retail pharmacy, pharmacy benefits management, government and consulting) – each with their own unique culture and vision. I am an agile and resourceful leader, recognized for my collaborative approach to problem-solving. Driven to achieve success, I have established a reputation of efficiently managing teams to excel and deliver outstanding results.

My expertise is in systematically analyzing opportunities and transforming creative strategies into executable business cases in the areas of marketing, operations, market access, and business development.

All Sessions by Kevin Wong

Printer Friendly See Full Agenda

Agenda: Day 1 Oct 5, 2020

Agenda: Day 2 Oct 6, 2020

10:00 am

10:00 am


Using Cardiovascular Disease As An Important Example

The healthcare system in Canada has been under tremendous strain for years. The ongoing crisis has been amplified by the pandemic, which caused severe global disruption in the delivery of health care for non-communicable diseases, BUT early detection and diagnosis are critical to keeping people out of hospitals and reducing the need for procedures and surgeries.

Now is the time to take a closer look at how the public and private sectors can band together to drive solutions to crucial healthcare problems, alleviate pressure throughout the system, and drive positive and lasting change.

The issue of cardiovascular disease (CVD) is particularly pressing as it is the second leading cause of death in Canada after cancer and now providers are facing an unprecedented backlog in the need for follow-up care to prevent future heart attacks and strokes among people at elevated risk. Novartis is seeking to address care inequities, barriers to access, and challenges and opportunities, by investing and institutionalizing best-in-class provincial teams to drive partnerships at the local healthcare system level.